| Danshen injection |
Alzheimer's disease |
0.001449576 |
| Amyotrophic lateral sclerosis (ALS) |
0.002621024 |
| Arginine and proline metabolism |
0.002621024 |
| Calcium signaling pathway |
0.013054225 |
| Danhong injection |
Complement and coagulation cascades |
1.81×10−4
|
| Calcium signaling pathway |
0.002275268 |
| Pancreatic cancer |
0.0022982 |
| Bladder cancer |
0.004186758 |
| Amyotrophic lateral sclerosis (ALS) |
0.008048873 |
| Arginine and proline metabolism |
0.008048873 |
| Alzheimer's disease |
0.008451764 |
| T cell receptor signaling pathway |
0.00977219 |
| Pathways in cancer |
0.012811104 |
| Neuroactive ligand-receptor interaction |
0.013931431 |
| Chronic myeloid leukemia |
0.020602331 |
| Asthma |
0.021425886 |
| Colorectal cancer |
0.027698349 |
| Allograft rejection |
0.032121033 |
| Prostate cancer |
0.032138092 |
